Table 2.
Demographics by FBP expression
| Characteristic | FBP hi | FBP lo | P‐value |
|---|---|---|---|
| Median Age (y) | 58 | 61 | 0.753 |
| (IQR 1‐3) | (53‐63) | (54‐67) | |
| Race (%) | 0.367 | ||
| Asian | 1 (5.3) | 0 (0) | |
| Black | 0 (0) | 0 (0) | |
| Caucasian | 17 (89.5) | 18 (100) | |
| Hispanic | 1 (5.3) | 0 (0) | |
| Histology (%) | 0.216 | ||
| Ovarian | 17 (89.5) | 14 (77.8) | |
| Endometrial | 1 (5.3) | 4 (22.2) | |
| Fallopian | 0 (0) | 0 (0) | |
| Peritoneal | 1 (5.3) | 0 (0) | |
| Grade (%) | 0.366 | ||
| 1 | 1 (5.3) | 2 (11.1) | |
| 2 | 1 (5.3) | 3 (18.7) | |
| 3 | 17 (89.5) | 12 (66.7) | |
| FIGO stage (%) | 0.041 | ||
| I | 1 (5.3) | 4 (22.2) | |
| II | 2 (10.5) | 3 (16.7) | |
| III | 14 (73.7) | 5 (27.8) | |
| IV | 2 (10.5) | 6 (33.3) | |
| Nodal status (%) | 0.476 | ||
| Negative | 14 (73.7) | 15 (83.3) | |
| Positive | 5 (26.3) | 3 (16.7) | |
| Disease status (%) | 0.068 | ||
| Primary | 12 (63.2) | 16 (88.9) | |
| Prior recurrence | 7 (36.8) | 2 (11.1) |